Stock A185750 CHONG KUN DANG PHARMACEUTICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Chong Kun Dang Pharmaceutical Corp.

Equities

A185750

KR7185750007

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
101,100 KRW +0.50% Intraday chart for Chong Kun Dang Pharmaceutical Corp. +1.92% -22.77%
Apr. 25 Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on January 23, 2024. CI
Jan. 23 Chong Kun Dang Pharmaceutical Corp. announces an Equity Buyback for KRW 15,000 million worth of its shares. CI

Chart calendar Chong Kun Dang Pharmaceutical Corp.

360a5cb84dda17ef65cb0.9KQxAgEfgSTMYKOK6SNfgfROt2e9kgQsvpk12Hq3_1w.v_t1MyxF7QmoP9vpr0Al5oEr-QHz4E56xKBw7C6Gq2yh3EVBdk21VK0YwA~bdf61e7d37502e476fd43c6227467905

Upcoming events on Chong Kun Dang Pharmaceutical Corp.

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-12 Q2 2024 Earnings Release (Projected)
2025-04-06 Q4 2024 Earnings Release (Projected)
2025-05-18 Q1 2025 Earnings Release (Projected)

Past events on Chong Kun Dang Pharmaceutical Corp.

2024-03-19 Q4 2023 Earnings Release
2023-05-14 Q1 2023 Earnings Release
2023-03-13 Q4 2022 Earnings Release
2022-08-15 Interim 2022 Earnings Release
2022-05-15 Q1 2022 Earnings Release
2021-08-16 Interim 2021 Earnings Release
2021-05-16 Q1 2021 Earnings Release
2021-02-07 FY 2020 Earnings Release
2020-03-29 FY 2019 Earnings Release
2019-11-13 Q3 2019 Earnings Release
2019-05-14 Q1 2019 Earnings Release
2018-07-25 Interim 2018 Earnings Release
2017-04-23 Q1 2017 Earnings Release

Past dividends on Chong Kun Dang Pharmaceutical Corp.

2023-12-26 Annual 1100 KRW
2022-12-27 Annual 1000 KRW
2021-12-28 Annual 1000 KRW
2020-12-28 Annual 1000 KRW
2019-12-26 Annual 900 KRW
2018-12-26 Annual 900 KRW
2017-12-26 Annual 900 KRW
2016-12-27 Annual 900 KRW
2015-12-28 Annual 600 KRW
2014-12-28 Annual 800 KRW

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW		Released
Forecast
Spread 		1 079
1 070
0.85%		1 301
1 310
-0.72%		1 334
1 337
-0.24%		1 472
1 463
0.61%
1 633


1 549

EBITDA
Billions KRW		Released
Forecast
Spread 		94,8
95,2
-0.5%		145
161
-9.83%		119
137
-12.77%		138
141
-2.37%
260


152

EBIT
Billions KRW		Released
Forecast
Spread 		77,0
74,5
3.42%		127
139
-8.61%		94,1
113
-16.67%		107
111
-3.93%
226


117

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		72,7
70,7
2.9%		120
134
-10.43%		77,4
95,2
-18.7%		101
108
-6.21%
229


112

Net income
Billions KRW		Released
Forecast
Spread 		53,9
50,3
7.04%		88,7
100
-11.61%		39,4
53,4
-26.14%		82,9
85,2
-2.63%
201


88,5

EPS
KRW		Released
Forecast
Spread 		4 300
3 800
13.17%		7 082
7 579
-6.56%		3 168
4 098
-22.68%		6 771
6 443
5.1%
15 391


6 960

Announcement Date31/01/2008/02/2110/02/2203/02/23--

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Billions KRW		Released
Forecast
Spread 		355
357
-0.58%		338
335
0.95%		365
352
3.73%		381
371
2.6%		389
379
2.49%		360
357
0.88%		392
378
3.63%		396
397
-0.26%
504


355


380


393


400


381

EBITDA
Billions KRW		Released
Forecast
Spread
























121


33,8


36,0


39,5


39,6


38,1

EBIT
Billions KRW		Released
Forecast
Spread 		0,99
20,9
-95.28%		24,3
22,7
7.41%		28,1
26,1
7.75%		39,7
35,8
10.78%		15,0
18,2
-17.31%		30,1
29,0
3.66%		43,4
34,0
27.72%		53,1
48,1
10.34%
116


25,4


29,7


33,2


25,9


30,2

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		0,35
18,6
-98.1%		23,6
17,0
38.88%		26,0
20,8
25.37%		37,7
35,9
4.98%		13,6
21,6
-37.11%		30,3
28,0
8.24%		43,3
33,3
29.89%		52,6
45,9
14.65%
115


25,3


29,3


33,1


21,2


28,0

Net income
Billions KRW		Released
Forecast
Spread 		-0,91
6,35
-114.35%		17,2
15,8
8.78%		24,5
17,2
42.18%		29,2
24,8
17.94%		12,1
12,7
-4.6%		34,9
22,0
58.58%		41,8
25,9
61.67%		43,5
39,3
10.86%
93,4


21,0


23,7


27,0


19,6


22,0

Announcement Date10/02/2229/04/2229/07/2228/10/2203/02/2315/05/2328/07/2327/10/23------

Upcoming sector events for Chong Kun Dang Pharmaceutical Corp.

2024-04-28 CHONGQING PHARSCIN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-28 SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.: Q1 2024 Earnings Release
2024-04-29 SINOTHERAPEUTICS INC.: Q4 2023 Earnings Release
2024-04-29 KUNMING LONGJIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 OTSUKA HOLDINGS CO., LTD.: Q1 2024 Earnings Release
2024-04-29 YIFAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-29 HANMI PHARM. CO., LTD.: Q1 2024 Earnings Release
2024-05-01 AJANTA PHARMA LIMITED: Q4 2024 Earnings Release (Projected)
2024-05-01 PROCTER & GAMBLE HEALTH LIMITED: Q3 2024 Earnings Release (Projected)
2024-05-06 SANDOZ GROUP AG: Q1 2024 Sales and Revenue Release
More events

Past sector events for Chong Kun Dang Pharmaceutical Corp.

Today HYBIO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today APICHOPE PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
Today YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.: Q1 2024 Earnings Release
Today HARBIN GLORIA PHARMACEUTICALS CO., LTD: Q1 2024 Earnings Release
Today SHANGHAI HAIXIN GROUP CO., LTD.: Q1 2024 Earnings Release
Today ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.: Q4 2023 Earnings Release
Today HYBIO PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-25 SINOTHERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A185750 Stock
  4. Calendar Chong Kun Dang Pharmaceutical Corp.